Syndemics Predict Bio-Behavioral HIV Sexual Transmission Risk Behavior Longitudinally in US HIV Clinics Satyanand Satyanarayana, Steven A. Safren, Brooke.

Slides:



Advertisements
Similar presentations
Diagnosis and Management of Acute HIV Infection HIV Clinical Guidelines from the New York State Department of Health AIDS Institute January 2010 HIV CLINICAL.
Advertisements

Risk Factors for Early Syphilis Among Men Who Have Sex With Men Seen in an STD Clinic – San Francisco, STD Prevention Conference: March 10, 2004.
PMTCT FAILURE: THE ROLE OF MATERNAL AND FACILITY –RELATED FACTORS ICASA Presentation 8 th to 12 th Dec 2013 Onono Maricianah 1, Elizabeth A. Bukusi 1,
Predictors of Change in HIV Risk Factors for Adolescents Admitted to Substance Abuse Treatment Passetti, L. L., Garner, B. R., Funk, R., Godley, S. H.,
1 Effect of Maternal HAART on Postnatal HIV-1 Transmission after Cessation of Extended Infant Antiretroviral Prophylaxis Taha Taha 1, Johnstone Kumwenda.
STD Screening in HIV Clinics: Value and Implications Thomas Farley, MD MPH Tulane University Deborah Cohen, MD MPH RAND Corporation.
Integration with ART for HIV+ Heterosexual men Risk of Resistance MSM High-risk women Young MSM of color Transgender women Long-term safety Provider attitudes.
C. Andres Bedoya, PhD Behavioral Medicine Service Department of Psychiatry Massachusetts General Hospital / Harvard Medical School Factors related to high-risk.
Virologic and immunologic response following antiretroviral therapy initiation among pregnant and postpartum women with acute HIV-1 infection: MOPDB0101.
Clinician Practices in Assessing Risk Behavior in US HIV Clinics Carol Dawson Rose, Grant Colfax, Lisa Metsch, David Mc Kirnan and Cari Courtenay-Quirk.
Predictors of HIV Transmission Risk among Patients in Care: Results from the SPNS Prevention with Positives Initiative Stephen F. Morin, PhD Principal.
Gender Competency Training for Medical Educators 28 th of April 2003 Evidence of gender difference and its clinical significance Ann-Maree Nobelius Faculty.
Patients in routine HIV clinical care at-risk for potentially transmitting HIV in the “test and treat” era of HIV prevention Crane, HM, Mimiaga, M, Feldman,
Phylogenetic Insight into HIV Transmission Networks in a Southeastern US Cohort Ann Dennis 1, Stéphane Hué 2, Christopher Hurt 1, Sonia Napravnik 1, Deenan.
RTI International is a trade name of Research Triangle Institute Untreated chlamydial infection among adolescents and young adults in Baltimore,
Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.
Sustained Treatment as Prevention: Unprotected sex and increases in virological suppression after HAART initiation among participants in HPTN K.H.
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
WIHS was established in 1993 to investigate the impact and progression of HIV in women.
Neurocognitive Impairment in HIV-Infected Subjects on HAART: Prevalence and Associations Kevin Robertson *1, Kunling Wu 2, Thomas Parsons 1, Ron Ellis.
Anticipated Risk Compensation with Pre-Exposure Prophylaxis Use among North American Men who have Sex with Men Using an Internet Social Network D Krakower,
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
Positive Prevention for HIV+ Injection Drug Users Kelly Knight, Debra Allen, Caryn Pelegrino, Barbara Garcia and Jeff Moore.
Supported by: NIAID/NHLBI R24 AI067039, NIAID R21 AI Viremia copy-years: A measure of cumulative HIV burden among patients initiating antiretroviral.
Social and Behavioral Sciences Research Network CFAR CFAR Social and Behavioral Sciences Research Network (SBSRN) 4 th Scientific Meeting Boston, MA September.
Richard Wolitski, PhD Division of HIV/AIDS Prevention Housing and Health : A CDC Perspective July 21, 2012 AIDS 2012 International Housing Summit World.
Correlates of HIV incidence among black men who have sex with men in 6 U.S. cities (HPTN 061) B. KOBLIN, K. MAYER, S. ESHLEMAN, L. WANG, S. SHOPTAW, C.
Michael J. Mugavero, MD, MHSc Associate Professor of Medicine University of Alabama at Birmingham Birmingham, Alabama Elements of the Care Continuum FORMATTED:
Alcohol and AIDS: A New Decade Grantsmanship Workshop XIX International AIDS Conference Rome, Italy Kendall J. Bryant, Ph.D., NIAAA Alcohol and AIDS Research.
The Contribution of Early HIV Infection to HIV Spread in Lilongwe, Malawi: Implications for Transmission Prevention Strategies Kimberly Powers, 1 Azra.
The Impact of Darunavir/ritonavir (DRV/r) & Raltegravir (RAL) in the Clinic: A New Era for Treatment-Experienced Patients? M. Mugavero 1, H. Lin 1, J.
North Carolina TASC Clinical Series Training Module Four: Brief Risk Intervention.
XVII Annual International AIDS Conference SHAZ! Shaping the Health of Adolescents in Zimbabwe Mudekunye, S. Laver University of Zimbabwe-University of.
Background  Substance abusers are at risk for HIV and other STIs.  Anal intercourse (AI) is riskier than vaginal intercourse.  Studies of AI have focused.
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
HIV TREATMENT FOR WOMEN IN UGANDA: INCREASING ACCESS THROUGH INTEGRATED SERVICE PROVISION J McGrath 1, S Rundall 1, D Kaawa-Mafigiri 1, N Kakande 2 1 Case.
Differences between undiagnosed, HIV-positive and HIV-negative Black transgender women in the United States: Results from POWER Presented by Leigh A. Bukowski,
Expanded PrEP implementation across Australia Expanded implementation of PrEP across Australia 1.
Funding Opportunities at the NIH-funded Centers for AIDS Research
Guanira J1, Lama JR1, Goicochea P1, Segura P1, Montoya O2, Sánchez J1
HPTN 071 (PopART): Have we reached the targets after two years of the PopART intervention IAS Paris July 2017 Richard Hayes.
Hepatitis C.
State Office of AIDS Update
1University of Kentucky, Lexington, Kentucky
Department of Epidemiology
Keio University of School of Medicine
Melanie L. Fritza Ronald J. Lubelchek, MD a, b, c*
The Relational Context of Non-disclosure in HIV Positive Women
Rectal Microbicides: Where We’re Heading
Conclusions & Implications
VACS Alcohol and Behavior Change Core
John de Wit1,2, Dean Murphy2,3, Luxi Lal4,5,6, Jennifer Audsley5,7, Christopher K. Fairley8,9, Mark Stoove4,10, Norm Roth11, Richard Moore12, Ban K.
HIV Testing:.
Engagement in methadone maintenance therapy associated with less time with plasma HIV-1 RNA viral load above 1500 copies/mL among a cohort of HIV-positive.
Elements of the Care Continuum
Behavioral Activation Integrated with Sexual Risk Reduction Counseling for High-Risk MSM with Crystal Methamphetamine.
Authors1 for the CFAR Network of Integrated Clinical Systems (CNICS)
Community Mobilization: Design
Poster WP41; Contact: David A. Katz,
Poster THP 55; Contact: David Katz,
VACS Scientific Meeting Houston, TX February 2004
Risk Stratification for Care Management
From Innovation to Commercialization Access to Data
Lesson 3: Treatment as Prevention
Stakeholder engagement and research utilization: Insights from Namibia
Receipt of medication-assisted treatment halves the risk of HIV-1 RNA viral load rebound for HIV-positive women who use illicit drugs Joëlla W. Adams,
The Hepatitis C treatment cascade in the era of direct-acting antivirals (DAAs), and barriers to DAA treatment initiation, among US men and women with.
MSM Attending STD Clinics HIV Testing More Frequently: Implications for HIV Prevention and Surveillance D Helms1, H Weinstock1, K Mahle1, A Shahkolahi1,2,
Screening for mental and substance use disorders among adolescents on ART in Southern Africa
Effect of Hepatitis C Eradication on Markers of Macrophage Activation and Microbial Translocation in HIV Seropositive Women Kerianne Burke1, Elizabeth.
Presentation transcript:

Syndemics Predict Bio-Behavioral HIV Sexual Transmission Risk Behavior Longitudinally in US HIV Clinics Satyanand Satyanarayana, Steven A. Safren, Brooke G. Rogers, Sierra Bainter, Katerina A. Christopoulos, Rob J. Fredericksen, William C. Mathews, Richard D. Moore, Michael J. Mugavero, Sonia Napravnik, Matthew J. Mimiaga, Kenneth H. Mayer, and Heidi M. Crane Syndemics Co-occurring psychosocial conditions that exacerbate risk for HIV transmission Usually studied in context of populations at risk of contracting HIV Less known about HIV transmission risk created by syndemics occurring in HIV-infected patients receiving clinical care Syndemics could help identify patients to receive psychosocial intervention to curb new HIV transmissions CNICS Network of CFAR sites providing patients with clinical care Health information collected at patient visits with patient-reported outcomes (PROs) collected at visits at least 4-6 months apart 15 727 pts from July 2000 to April 2017 68 984 total visits (mean 4.4 visits/pt) Acknowledgments CNICS is an NIH-funded program (R24 AI067039) made possible by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Heart, Lung, and Blood Institute (NHLBI). The CFAR sites involved in CNICS include Univ of Alabama at Birmingham (P30 AI027767), Univ of Washington (P30 AI027757), Univ of California San Diego (P30 AI036214), Univ of California San Francisco (P30 AI027763), Case Western Reserve Univ (P30 AI036219), Johns Hopkins Univ (P30 AI094189, U01 DA036935), Fenway Health/Harvard (P30 AI060354), and Univ of North Carolina Chapel Hill (P30 AI50410). Author time was supported by 9K24 DA040489 (Safren) and by the University of Miami Dean’s Fellowship. Conflicts of Interest No conflicts to disclose

Analysis Predictors Outcome No. of syndemics Bio-behavioral transmission risk behavior (TRB): condomless sex while virally detectable (HIV RNA > 400) with a partner of unknown or HIV-negative status Depression (PHQ-9) Anxiety (Brief PHQ) Alcohol Use (AUDIT-C) Drug Use (ASSIST) Time (measured by visit number) Behavioral risk group

Results } Cis women as referent group Conclusions Identifying syndemics via patient-report-outcome measures in HIV clinics is feasible. Integrating the identification and treatment of syndemic conditions within HIV clinical settings carries potential for reducing the number of new infections via bio-behavioral transmission risk behavior.